A new study from researchers at the University of Basel demonstrates that a novel cancer immunotherapy, based on a locally focused activation of immune cells, could help to more efficiently eradicate tumor cells and reduce side effects.
Cancer immunotherapies make use of the ability of the immune system to attack cancer cells: they unleash the killer function of T cells, which then attack and eradicate the cancer cells.
However, tumors have their own mechanisms to paralyze these attacks. Despite major advances in immunotherapies, there are a large number of cancer patients whose tumors have proved resistant. Immunotherapies can also lead to severe side effects.
Researchers led by Professor Alfred Zippelius at the University of Basel and University Hospital Basel have investigated the immune responses induced by a new approach: a cancer immunotherapy that attacks the tumor in a targeted and efficient manner.
The study was carried out in collaboration with the Roche Innovation Center Zurich and the Cantonal Hospital Baselland, and was recently reported in the Journal for ImmunoTherapy of Cancer.
Locally focused effect
The approach is based on a molecule that stimulates T cells – but only if they are in the immediate vicinity of the tumor. The targeted effect is based on the fact that the active substance only binds to and activates T cells when it is bound to a specific protein expressed in the tumor environment.
“By binding to T cells, the active substance enhances their killer function,” says Dr. Marta Trüb, a postdoc in Zippelius’ research group and one of the lead authors of the study.
The ‘switch’ on the T cells activated by the drug is called 4-1BB. This T cell receptor had already been identified as a promising target for immunotherapy. However, previous therapeutic approaches failed due to severe side effects. “With this novel approach, the effect is focused on the tumor and spares the rest of the body,” explains Trüb.
The researchers achieved promising results in experiments with tumors isolated from lung and ovarian cancer patients: the T cells stimulated with the new approach showed increased proliferation and released messenger substances that supported the attack on the cancer cells.
Based on their results, the researchers hope that this new approach will proceed to clinical trials in the future.
Prof. Dr. Alfred Zippelius, University of Basel / University Hospital Basel, email: email@example.com
Marta Trüb, Franziska Uhlenbrock, Christina Claus, Petra Herzig, Martin Thelen, Vaios Karanikas, Marina Bacac, Maria Amann, Rosemarie Albrecht, Claudia Ferrara-Koller, Daniela Thommen, Sacha Rothschield, Spasenija Savic Prince, Kirsten D Mertz, Gieri Cathomas, Robert Rosenberg, Viola Heinzelmann-Schwarz, Mark Wiese, Didier Lardinois, Pablo Umana, Christian Klein, Heinz Laubli, Abhishek S Kashyap, Alfred Zippelius
Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer
Journal for ImmunoTherapy of Cancer (2020), doi: 10.1136/jitc-2019-000238
Dr. Angelika Jacobs | Universität Basel
A new way to target cancers using 'synthetic lethality'
28.07.2020 | University of California - San Diego
VISION - Strategies to strengthen scientific excellence and innovation in early diagnosis of stomach and colon cancer
28.07.2020 | Fraunhofer-Institut für Biomedizinische Technik IBMT
“Core-shell” clusters pave the way for new efficient nanomaterials that make catalysts, magnetic and laser sensors or measuring devices for detecting electromagnetic radiation more efficient.
Whether in innovative high-tech materials, more powerful computer chips, pharmaceuticals or in the field of renewable energies, nanoparticles – smallest...
An international research team with Prof. Cornelia Denz from the Institute of Applied Physics at the University of Münster develop for the first time light fields using caustics that do not change during propagation. With the new method, the physicists cleverly exploit light structures that can be seen in rainbows or when light is transmitted through drinking glasses.
Modern applications as high resolution microsopy or micro- or nanoscale material processing require customized laser beams that do not change during...
Although no life has been detected on the Martian surface, a new study from astrophysicist and research scientist at the Center for Space Science at NYU Abu...
New approach creates synthetic layered magnets with unprecedented level of control over their magnetic properties
The magnetic properties of a chromium halide can be tuned by manipulating the non-magnetic atoms in the material, a team, led by Boston College researchers,...
Scientists of Tomsk Polytechnic University jointly with a team of the V.E. Zuev Institute of Atmospheric Optics of the Siberian Branch of the Russian Academy of Sciences have discovered a method to increase the operation range of optical traps also known
Optical tweezers are a device which uses a laser beam to move micron-sized objects such as living cells, proteins, and molecules. In 2018, the American...
23.07.2020 | Event News
21.07.2020 | Event News
07.07.2020 | Event News
30.07.2020 | Health and Medicine
30.07.2020 | Materials Sciences
30.07.2020 | Life Sciences